Farallon Capital

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
Enanta Pharmaceuticals, Inc.
ENTA
$36.58M9.892.1M+3.46%+$1.22M0.26
Agios Pharmaceuticals, Inc.
AGIO
$163.47M9.855.59M+34.14%+$41.61M1.15
Protagonist Therapeutics, Inc.
PTGX
$166.03M9.795.74M+0.08%+$131,428.991.17
Exelixis, Inc.
EXEL
$633.08M9.1626.68M+0.17%+$1.04M4.45
Longboard Pharmaceuticals, Inc.
LBPH
$63.51M7.562.94M+88.43%+$29.81M0.45
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.